Screener
USANA Health Sciences USNA Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $7.52M-20.1% | —— | -$6.52M-161% | $9.66M-7.4% | $9.4M-43.1% | ||
| $22.15M-7.7% | $12.38M+1.4% | $9.14M-52.3% | $24.46M+13.0% | $24.01M-13.7% | ||
| $13.87M-11.5% | $3.82M-53.5% | $1.22M-92.2% | $16.72M-6.3% | $15.67M-36.5% |
FAQ
- What is USANA Health Sciences's revenue?
- USANA Health Sciences (USNA) generated $925.9M in revenue over the trailing twelve months, up 5.7% year over year.
- Is USANA Health Sciences profitable?
- USANA Health Sciences reported $20.1M in net income over the trailing twelve months, a 1.9% net margin.
- What are USANA Health Sciences's profit margins?
- Gross margin is 77.6% and operating margin is 3.8%, with a 1.9% net margin.
- What is USANA Health Sciences's earnings per share?
- USANA Health Sciences's diluted EPS over the trailing twelve months is $1.06.
- Where does USANA Health Sciences's income statement data come from?
- Every line is extracted from USANA Health Sciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
